• Nenhum resultado encontrado

Rev. Bras. Anestesiol. vol.67 número4

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Anestesiol. vol.67 número4"

Copied!
5
0
0

Texto

(1)

REVISTA

BRASILEIRA

DE

ANESTESIOLOGIA

Publicação Oficial da Sociedade Brasileira de Anestesiologia

www.sba.com.br

SCIENTIFIC

ARTICLE

Remifentanil

does

not

increase

urine

output

during

oral

surgery,

contrary

to

its

effect

during

other

surgeries

---

a

cohort

study

Kentaro

Ouchi

,

Kazuna

Sugiyama

KagoshimaUniversityGraduateSchoolofMedicalandDentalSciences,FieldofOralandMaxillofacialRehabilitation, DepartmentofDentalAnesthesiology,Kagoshima,Japan

Received25November2015;accepted16December2015 Availableonline29April2016

KEYWORDS

Remifentanil;

Urineoutput;

Generalanesthesia

Abstract

Background: Anincreaseinurineoutputbyremifentanilinjectionduringlaparoscopic proce-duresandsurgeriessuchascardiacandgynecologicalprocedures,duetosuppressionofthe stressresponsetosurgery,hasbeenreported.Theaimofourprospective,observational,cohort studywastoassesstheeffectofremifentanilanalgesiaonurineoutputduringdentalandminor oralsurgerybycomparingintraoperativeurineoutputunderdefinedinfusionvolumeswithand withouttheuseofremifentanil.

Methods:Dentalpatientsaged16yearsorolder,AmericanSocietyofAnesthesiologistsphysical status1,withnorenaldiseasesorabnormalbloodvaluesofserumcreatinineandBUN,noton treatmentwithdiureticdrugs,andundergoingminororo-maxillofacialsurgeryordental treat-mentunderinhalationgeneralanesthesiawereincludedinthisstudy.Urethralcatheterization wasperformedafteranesthesiainduction,andurineoutputwasmeasuredevery30minutes. Wemeasuredurinevolume(mL)andrateofurineoutput(mL.kg−1.h−1)intraoperatively,and comparedtheseparametersbetweenpatientswhodidanddidnotreceiveremifentanilduring theintraoperativeperiod.

Results:Eighty-sevenpatientswerecategorizedintotheremifentanilgroup(n=43)or remifen-tanilnon-usegroup(n=44).Bothvolumeofurine(mL)andrateofurineoutput(mL.kg−1.h−1) werenotsignificantlydifferentbetweenthetwogroups(remifentanilgroup,372.3±273.5mL, 1.8±1.1mL.kg−1.h−1; remifentanilnon-use group, 343.3±283.3mL,1.9±1.2mL.kg−1.h−1; p=0.63;0.57).

Correspondingauthor.

E-mail:ken2006anes@yahoo.co.jp(K.Ouchi).

http://dx.doi.org/10.1016/j.bjane.2015.12.004

(2)

Conclusion: Ourresultsshowthatuseofremifentanilduringdental andminororalsurgeries doesnotincreaseurineoutput.

©2016SociedadeBrasileiradeAnestesiologia.Publishedby ElsevierEditoraLtda.Thisisan openaccessarticleundertheCCBY-NC-NDlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PALAVRAS-CHAVE

Remifentanil; Diurese;

Anestesiageral

Remifentanilnãoaumentaadiuresedurantecirurgiaoral,contrariamenteaoseu efeitoduranteoutrascirurgias---estudodecoorte

Resumo

Justificativa: Foirelatadoumaumentonadiureseapósainjec¸ãoderemifentanildurante pro-cedimentoslaparoscópicosecirurgiascardíacaseginecológicas,devidoàsupressãodaresposta aoestressedacirurgia.Oobjetivodenossoestudoprospectivo,observacionaledecoortefoi avaliaroefeitodaanalgesiacomremifentanilsobreadiuresedurantecirurgiaodontológicae oraldepequenoporteecompararadiuresenointraoperatóriosobinfusãodevolumesdefinidos, comesemousoderemifentanil.

Métodos: Pacientesodontológicos≥16anos,estadofísicoASAI,semdoenc¸asrenaisouvalores sanguíneosanormaisdecreatininaséricaeureia,semtratamentocomdiuréticose submeti-dosàcirurgia bucomaxilofacialdepequenoporteoutratamentoodontológicosobanestesia geralinalatóriaforamincluídosnesteestudo.Cateterismouretralfoifeitoapósainduc¸ãoda anestesiaeadiuresefoimedidaacada30min.Medimosovolumedeurina(mL)eataxade diurese(mL.kg−1.h−1)nointraoperatórioecomparamosessesparâmetrosentreospacientes quereceberamequenãoreceberamremifentanilduranteoperíodointraoperatório.

Resultados: Foramdesignados87pacientesparaosgruposcomremifentanil(n=43)ougrupo semremifentanil(n=44).Ovolumedeurina(mL)eataxadediurese(mL.kg−1.h−1)nãoforam significativamentediferentesentreosdoisgrupos(grupocomremifentanil:372,3±273,5mL, 1,8±1,1mL.kg−1.h−1;gruposemremifentanil:343,3±283,3mL,1,9±1,2mL.kg−1.h−1;p= 0,63;0,57).

Conclusão:Nossos resultadosmostramqueouso deremifentanilduranteascirurgias odon-tológicasedepequenoportenãoaumentaadiurese.

©2016SociedadeBrasileiradeAnestesiologia.PublicadoporElsevierEditoraLtda.Este ´eum artigo OpenAccess sobumalicenc¸aCCBY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Introduction

Reportedly, remifentanil increases urine output during surgery, probably by preventing the stress response to surgery.1---5Previousstudiesonincreasesinurineoutputdue toremifentanil were performed duringlaparoscopic, car-diac,or gynecological surgeries,but itseffectduringoral andmaxillofacialtreatmenthasnotbeenreported.

Theaimofourobservationalstudywastocompareurine outputduringuseofremifentanilversusnon-useof remifen-tanil in patients undergoing minor oral surgery or dental procedures,bymeasuringurineoutputunderdefined infu-sionvolumesintheintraoperativeperiod.

Methods

Dental patients aged 16 years or older, undergoing minor oro-maxillofacial surgery and dental treatment under inhalationalgeneralanesthesiaattheClinicalDepartment

ofDentalAnesthesia,KagoshimaUniversityMedicalDental HospitalfromApril2011toMarch2014werestudied.Tobe includedinthestudy,patientshadtobeAmericanSociety ofAnesthesiologistsphysicalstatus1.Patientswithknown renaldisease,laboratorydataindicativeofabnormalblood valuesofserumcreatinineandBloodUreaNitrogen(BUN), andthoseontreatmentwithdiureticdrugswereexcluded. Informed consentfor oral surgeryand for participationin thisstudyundergeneralanesthesiawasobtainedfromeach patient.The institutionalreview board of Kagoshima Uni-versityMedicalDentalHospitalapprovedthestudyprotocol, whichwasconductedinaccordancewiththeDeclarationof Helsinki.

(3)

Table1 Demographicsofpatientsintheremifentaniluseandnon-usegroups.

Age(years) Height(cm) Weight(kg) Male/female

Remifentanilgroup 43.5±17.1 162.8±8.9 60.4±12.3 21/22

Nonusegroup 41.8±15.0 160.8±10.4 57.7±12.0 25/19

p-Value 0.61 0.35 0.32 0.52

Anesthesiatime(min) Operationtime(min) Infusionvolume(mL) Bloodloss(mL)

Remifentanilgroup 209.1±70.5 120.8±64.3 981±349 19.3±18.0

Nonusegroup 184.5±84.5 104.6±76.9 862±351 26.6±40.5

p-Value 0.15 0.30 0.12 0.30

Anesthesiaprotocol

According to current recommendations, patients were

allowed solid foods for up to the night before surgery,

and clear fluids for up to 2.5h before general

anes-thesia induction. An intravenous line was secured for

administration of the isotonic fluid (140mEq.L−1 sodium

with 1% glucose; Physio140, Otsuka Pharmaceutical, Co.,

Ltd.,Tokyo,Japan).Furthermore,allpatientscontinuously

underwentnon-invasiveblood pressureand

electrocardio-graphicmonitoringusingastandardautomatedmonitoring

device(Marquette Solar8000M,GE Medical Systems,UK).

Anesthesia was induced with propofol 1.5mg.kg−1 IV,

and intubation was facilitated with the IV administration

of rocuronium 0.9mg.kg−1. In remifentanil-use cases, it

was administered at the rate of 0.25␮g.kg−1.min−1

dur-inganesthesia induction. Anesthesia wasmaintained with

sevoflurane (1.5%), nitrous oxide (4L.min−1) and oxygen

(2L.min−1). Remifentanil-use cases additionally received

a continuous infusion of remifentanil at the rate of

0.05---0.15␮g.kg−1.min−1.Remifentanilnon-usepatientsdid

notreceiveanyopioids. Remifentanil-usepatientsdidnot

receiveotheropioids.Localanesthesiawasusedbythe

sur-geons,asappropriate.Thesurgeonswereunawareoftheuse

or non-use of remifentanil.Rocuronium wasadministered

forintubation,withnoadditionaldosesbeingadministered

intraoperatively. All patients received 4.5mL.kg−1.h−1 of

thecrystalloid fluidwithan infusion pump fromthe time

of securing the intravenous line. Urethral catheterization

wasperformedafteranesthesiainductionandurineoutput

wasmeasured every 30min during anesthesia. If patients

developedhypotensionintraoperatively,withafallin

sys-tolicBPtolessthan80mm.Hg−1,remifentanilinfusionwas

temporarilydiscontinued,andtheyweregivenephedrine.

Thesepatientswerethenexcludedfromthestudy.All

anes-theticswerestoppedattheendofsurgery.

Measurementofparameters

Wemeasuredthetotalvolumeofurine(mL)andvolumeof

urineperkilogrambodyweightperunittime(mL.kg−1.h−1)

in all patients. We then compared these values between

remifentaniluseandnon-usegroups.

Statisticalanalyses

Continuousdemographicandlaboratoryvariableswere

com-paredusingtheunpairedt-test,andtheChi-squaretestwas

usedforcategoricalvariables.JMPsoftware(version10,SAS

InstituteInc.,Japan)wasusedforstatisticalanalysis,and

p<0.05wasregardedasbeingstatisticallysignificant.The

resultsarepresentedasmean±SD.

Results

Eighty-sevenpatientswereincludedinthisstudyandwere

categorizedintotheremifentanilgroup(n=43)or

remifen-tanil non-use group (n=44). Table 1 shows the patients’

demographicdataandTable2liststhesurgicalprocedures performed.Useofremifentanilwasattheattending anes-thesiologist’sdiscretion.Thestudysubjectswereattended tobyoneofthefouranesthesiologists.AnesthesiologistsA and B routinely administer remifentanil, and anesthesiol-ogistsCandDdonotroutinelyadministerremifentanil.In casesinwhichitwasused,remifentanilwasgiveninthedose rangeof0.05---0.15␮g.kg−1.min−1.Bloodpressureduringthe

intraoperativeperioddecreasedbymorethan15---25% com-paredwithpre-anesthesiavaluesinbothgroups.

Volume of urine (mL) and volume of urine per kilo-gram body weight per unit time (mL.kg−1.h−1) were not

significantlydifferentbetweenthetwogroups(remifentanil group, 372.3±273.5mL, 1.8±1.1mL.kg−1.h−1; non-use

group, 343.3±283.3mL, 1.9±1.2mL.kg−1.h−1; p=0.63;

0.57,respectively)(Table3).

Table2 Surgeriesperformedinthestudysubjects. Remifentanil

group

Nonusegroup

Toothextraction 15 19

Cystextirpation 15 16

Platesexclusion 4 2

Dentaltreatment 2 2

Cleftlipnasaldeformity 1 2

Dentalimplant 1 0

Incisionaldrainage 1 0

Sialolithextirpation 1 0

Bonetransplantation 0 1

Osteoplasty 2 1

Leukoplakiaexcision 1 1

(4)

Table3 Urineoutputwithandwithouttheuseof remifen-tanilduringdental/minororalsurgery.

Urineoutput (mL)

Weightilyhourly urineoutput (mL.kg−1.h−1)

Remifentanilgroup 372.3±273.5 1.8±1.1

Nonusegroup 343.3±283.3 1.9±1.2

p-Value 0.63 0.57

Discussion

The purpose of this study was to evaluate the effect of

remifentanilonurineoutputin patientsundergoingminor

oralandmaxillofacialsurgeryundergeneralanesthesiawith

nitrous oxide and sevoflurane. The authors hypothesized

that remifentanilwould increase urine outputduring oral

surgeries,similartothatduringlaparoscopic surgeries,as

well ascardiac and gynecological procedures. We found,

however, that remifentanil does not increase urine

out-putduring dentaland oralsurgery. The mechanismof the

previously reported increase in urine volumeby

remifen-tanilisbelieved tobeasfollows.Adequateanalgesiawith

remifentanilreducesthesecretionofantidiuretichormone,

resulting in an increase in urine output. One of the

pre-vious reports states that the increase in urine volume

induced by remifentanil is accompanied by a decreasein

catecholamine secretionand a highly significant decrease

in cortisol excretion.1 In other reports, although the

lev-els of antidiuretic hormone, catecholamine and cortisol were not measured, their values were believed to have decreased.1,3---5 In all of these previous reports, the sur-geries performed were those in which local anesthesia alonewouldnotprovideadequateanalgesia.Inlaparoscopic surgeryfor example,becausea widerangeofanalgesiais requiredforincisionoftheperitoneum,epiduralanesthesia doesnotprovideadequateanalgesia.1Moreover,in laparo-scopicsurgery,acomparativelyhigherdoseofremifentanil isrequiredtodecreasethecatecholaminesecretioninduced bysurgicalstimulation.6Remifentanilinfluencestherelease of stressresponse markers,such asantidiuretichormone, ACTH, cortisol, noradrenaline and adrenaline.7,8 In this study,inboththegroups,irrespectiveoftheuseornon-use ofremifentanil,anesthesiawasmaintainedwithsevoflurane 1.5%,nitrousoxide66.6%andoxygen33.3%.Consequently, patients received 1.51 MAC of inhalational anesthetics, because1MACofsevofluraneis 1.71%andthatof nitrous oxideis 105%.Thus,the concentrationofanesthetics was sufficient for minor surgery. The procedures evaluatedin this study included minor oral surgeries, such as tooth extractionandcystextirpation.Minororalsurgeryisusually performed under local anesthesiaor localanesthesia and intravenousanesthesia/sedation(non-useofopioids).Even cleftlipdeformitycanberepairedunderlocalanesthesia.9 Thus,inoperationsinthisstudy,localanesthesiaand inhala-tionanestheticsprovidedadequateanalgesiainallsubjects, even those who did not receive remifentanil. We postu-latethattheabsenceofanincreaseinurineoutputunder remifentanilanalgesiaduringminororalanddentalsurgery,

asseen inthis study,is duetothefact thatinthese pro-cedures,anesthesiawithout remifentanil providesenough analgesiathatthe stress response,andhence, stress hor-monesreleaseis blunted,which results in minimal effect of remifentanil on these hormones and hence, on urine output.

Therehasbeennostudyinvestigatingthedirecteffect ofremifentanilonrenalfunction.However,previousstudies onthepreconditioningeffectofremifentanilhavereported thatalthoughremifentanilisa␮-receptoragonist,its car-dioprotective effect is mediated through ␬ and ␦ opioid receptors.Reportedly,␬receptoractionmayincreaseurine output,because ␬ agonists have been reported toinduce diuresisinanimalstudies.10,11However,urineoutputwasnot greaterintheremifentanilgroupinthisstudy.Thissuggests that␬receptoractionisnotresponsiblefortheincreasein urineoutput induced by remifentanil.Further studies are neededtoelucidatethemechanismofthediuresisinduced byremifentanil.

The type of fluid administered intraoperatively may affect urine output. It is reported that during use of 0.9%saline,increasedafferentarteriolarresistancereduces renalflowandglomerularfiltrationrate,leadingtoreduced urineoutput.12 Consequently,differenttypesoffluidsmay havedifferenteffectsonurineoutput.Thus,fluidinfusion inthisstudywasrestrictedtoasingletypeoffluid.Inthis study,fluidwasinfusedattherateof4.5mL.kg−1.h−1.For

a60kgpatient,whichwasthemeanweightofsubjectsin this study, this amounted to 270mL.h−1. If fluid

require-mentis calculatedbasedonthe 4-2-1rule(4mL.kg−1.h−1

for the first 10kg body weight, 2mL.kg−1.h−1 from11 to

20kg and 1mL.kg−1.h−1 for every kg above 20kg), this

would have amounted to 100mL.h−1 for a 60kg patient.

Thus,theamountofmaintenancefluidadministeredduring anesthesiawasan over dose,although thereasonfor this over-infusionwastocompensateforpreoperative dehydra-tionoverthe shorttimeperiodofthe operation(planned for0.5---2h).

In thisstudy, use of remifentanilwasat theattending anesthesiologist’sdiscretion.While the decision touse or notuse remifentanil differs according to the anesthesiol-ogist, the number of patients in the two groups in this study wasalmost identical.Further, sincethe rest of the anesthesiaprotocol,otherthanuseornon-useof remifen-tanil, was prescribed, the likelihood of operator bias, in terms of the attending anesthesiologist, in this study is minimal.

(5)

Conclusions

Inconclusion,our resultssuggest thatuse of remifentanil does not increase urine output during general anesthesia withnitrousoxideandsevofluranefordentalandminororal surgery.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

Acknowledgments

ThisworkwassupportedbytheDepartmentalResearchFund ofKagoshimaUniversity.Thisworkwaspresented,inpart, on October 10---12, 2014, at the 42th Annual Meeting of theJapaneseDentalSocietyofAnesthesiology(Chairperson: Prof.KimitoSano),Niigata.

References

1.IshikawaK, SakaiA, NagataH, et al.Remifentanil increases urine outputin patients undergoing laparoscopic colectomy. Masui.2012;61:526---30.

2.MylesPS,HuntJO,FletcherH,etal.Remifentanil,fentanyl,and cardiacsurgery:adouble-blinded,randomized,controlledtrial ofcostsandoutcomes.AnesthAnalg.2002;95:805---12[tableof contents].

3.OnakaM,YamamotoH.Remifentanilmaybebeneficialto uri-nary outputunderepidural-basedgeneral anesthesia.Masui. 2010;59:1391---5.

4.Yago Y, Tajiri O, Ito H, et al. Effect of remifentanil on urineoutputduringgynecologicallaparoscopicsurgery.Masui. 2009;58:613---5.

5.Kawai M, Nakata J, Kawaguchi M, et al. Comparison of urinary output during general anesthesia, between patients administeredwithremifentanilandthosewithoutremifentanil administration.Masui.2010;59:179---82.

6.MyreK, Raeder J, Rostrup M, et al. Catecholamine release duringlaparoscopicfundoplicationwithhighandlowdosesof remifentanil.ActaAnaesthesiolScand.2003;47:267---73. 7.MaranaE,ScambiaG,ColicciS,etal.Leptinandperioperative

neuroendocrinestressresponsewithtwodifferentanaesthetic techniques.ActaAnaesthesiolScand.2008;52:541---6.

8.WinterhalterM,BrandlK,Rahe-MeyerN,etal.Endocrinestress responseandinflammatoryactivationduringCABGsurgery.A randomizedtrialcomparingremifentanilinfusionto intermit-tentfentanyl.EurJAnaesthesiol.2008;25:326---35.

9.LalondeDH,PriceC,WongAL, etal.Minimally painfullocal anestheticinjectionforcleftlip/nasalrepairingrownpatients. PlastReconstrSurgGlobOpen.2014;2:e171.

10.KimJE,LeeJS,KimMK,etal.Nicardipineinfusionfor hypoten-sive anesthesia during orthognathic surgery has protective effect on renal function. J Oral Maxillofac Surg. 2014;72: 41---6.

11.Ashton N, Balment RJ, Blackburn TP. Kappa-opioid-induced changes in renal water and electrolyte management and endocrinesecretion.BrJPharmacol.1989;97:769---76. 12.SantiM, Lava SA, CamozziP, et al. The greatfluid debate:

salineor so-called ‘‘balanced’’salt solutions? ItalJ Pediatr. 2015;41:47.

Imagem

Table 1 Demographics of patients in the remifentanil use and non-use groups.
Table 3 Urine output with and without the use of remifen- remifen-tanil during dental/minor oral surgery.

Referências

Documentos relacionados

O problema da antinomia é decidir se: O desejo de felicidade pode ser causa motriz (Bewegursache) para as máximas da virtude, ou se a máxima da virtude pode ser a causa eficiente

Começando por uma evolução histórico-didática sobre como o Estado se tornou um garantidor de direitos fundamentais, passando pela existência do direito ao

Diante do desconhecimento e desvalorização das reais necessidades de saúde e bem-estar dos idosos, vinculada ao despreparo dos profissionais para lidarem com as questões sexuais

sua mensuração, muitas vezes se tornam difíceis e apresentam grandes falhas de interpretação. No teste do papel a paciente fica em posição supina, que é a posição

Devo dizer que numa abordagem panorâmica do material coletado3 o que se observa é a recorrência de dois valores: o poético, quase sempre associado a um fundo

Our study recommends the use of aspirin as the chemical prophyl- atic agent for venous thromboembolism in patients undergoing total hip arthroplasty, associated with the use

The analysis of the quality of life question- naire, WHOQOL-Old (Table 3), allowed verifica- tion that among the men there were statistically significant differences in the

Ousasse apontar algumas hipóteses para a solução desse problema público a partir do exposto dos autores usados como base para fundamentação teórica, da análise dos dados